How many insider trades does FilingIQ track for CING?

FilingIQ tracks 66 Form 4 insider transactions for CING (Cingulate Inc.), covering filings from Dec 10, 2021 onwards. 11 of those were filed in the last 90 days.

Are CING insiders net buyers or net sellers?

Across the full Form 4 history for CING, 47 transactions (71%) were open-market purchases and 2 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CING insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CING in?

Cingulate Inc. (CING) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $42.29M.

CING insider trading

Healthcare

Cingulate Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

71% / 3%

Market cap

$42.29M

About Cingulate Inc.

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Company website: www.cingulate.com

CING insider activity at a glance

FilingIQ has scored 66 insider transactions for CING since Dec 10, 2021. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 47 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CING insider trades is 70.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CING trades on FilingIQ Raw filings on SEC EDGAR

Latest CING Form 4 filings

Schaffer Shane J. Chief Executive Officer

P Feb 6, 2026

Callahan Jennifer L. SVP and CFO

P Feb 6, 2026

Brams Matthew EVP and Chief Medical Officer

P Feb 6, 2026

Myers Laurie EVP and COO

S Aug 15, 2024

Werth Peter J.

P Aug 11, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading CING

Schaffer Shane J.

4 trades · score 78.0

Callahan Jennifer L.

4 trades · score 76.0

Brams Matthew

4 trades · score 71.0

Frequently asked

How many insider trades does FilingIQ track for CING?: FilingIQ tracks 66 Form 4 insider transactions for CING (Cingulate Inc.), covering filings from Dec 10, 2021 onwards. 11 of those were filed in the last 90 days.
Are CING insiders net buyers or net sellers?: Across the full Form 4 history for CING, 47 transactions (71%) were open-market purchases and 2 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CING insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CING in?: Cingulate Inc. (CING) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $42.29M.

Methodology & sources

Every CING insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.